Ali Behbahani insider trades
Open-market stock purchases and sales by Ali Behbahani, Unknown at Black Diamond Therapeutics, Inc, from SEC Form 4 filings since Nov 5, 2014.
Track record: 50% of 14 scored buys are up 5% or more since purchase, averaging +3%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 18, 2026 | BDTX Black Diamond Therapeutics, Inc | Bought (not open market) | $14.9K |
| Sep 17, 2026 | CRSP CRISPR Therapeutics AG | Bought (not open market) | $420K |
| Sep 17, 2026 | CRSP CRISPR Therapeutics AG | Sold | $781K |
| Sep 17, 2026 | CRSP CRISPR Therapeutics AG | Bought (not open market) | — |
| Jul 1, 2026 | GLUE Monte Rosa Therapeutics, Inc | Sold (not open market) | — |
| Jul 1, 2026 | GLUE Monte Rosa Therapeutics, Inc | Bought (not open market) | — |
| Jul 1, 2026 | GLUE Monte Rosa Therapeutics, Inc | Sold (not open market) | — |
| Jun 26, 2026 | BDTX Black Diamond Therapeutics, Inc | Bought (not open market) | — |
| Jun 19, 2026 | BDTX Black Diamond Therapeutics, Inc | Bought (not open market) | $14.9K |
| Jun 11, 2026 | GLUE Monte Rosa Therapeutics, Inc | Bought (not open market) | — |
| Jun 10, 2026 | NKTX Nkarta, Inc | Bought (not open market) | — |
| Jun 10, 2026 | KRRO Korro Bio, Inc | Bought (not open market) | — |
| Jun 5, 2026 | CRSP CRISPR Therapeutics AG | Bought (not open market) | — |
| Apr 28, 2026 | ACLX Arcellx, Inc | Sold (not open market) | — |
| Apr 28, 2026 | ACLX Arcellx, Inc | Sold (not open market) | — |
| Apr 28, 2026 | ACLX Arcellx, Inc | Sold (not open market) | $435K |
| Apr 28, 2026 | ACLX Arcellx, Inc | Sold (not open market) | $411K |
| Apr 28, 2026 | ACLX Arcellx, Inc | Sold (not open market) | $584K |
| Mar 20, 2026 | BDTX Black Diamond Therapeutics, Inc | Bought (not open market) | $14.9K |
| Mar 10, 2026 | KRRO Korro Bio, Inc | Bought (not open market) | $2.3M |
| Mar 10, 2026 | KRRO Korro Bio, Inc | Bought (not open market) | $2.7M |
| Feb 9, 2026 | SGP SpyGlass Pharma, Inc | Bought | $15M |
| Feb 9, 2026 | SGP SpyGlass Pharma, Inc | Bought (not open market) | — |
| Feb 9, 2026 | SGP SpyGlass Pharma, Inc | Bought (not open market) | — |
| Feb 9, 2026 | SGP SpyGlass Pharma, Inc | Bought (not open market) | — |
Companies traded
- BDTX Black Diamond Therapeutics, Inc: 2 buys, last Sep 18, 2026
- CRSP CRISPR Therapeutics AG: 1 sale, last Sep 17, 2026
- GLUE Monte Rosa Therapeutics, Inc: 1 buy, last Jul 1, 2026
- NKTX Nkarta, Inc: other filings, last Jun 10, 2026
- KRRO Korro Bio, Inc: other filings, last Jun 10, 2026
- ACLX Arcellx, Inc: other filings, last Apr 28, 2026
- SGP SpyGlass Pharma, Inc: 1 buy, last Feb 9, 2026
- NEUE NeueHealth, Inc: 4 buys, 3 sales, last Oct 2, 2025
- ADAP Adaptimmune Therapeutics plc: 2 buys, 2 sales, last Aug 18, 2025
- MBX MBX Biosciences, Inc: 1 buy, last Sep 16, 2024
- CVRX CVRx, Inc: other filings, last Jun 4, 2024
- BHG Bright Health Group Inc: 10 buys, last Dec 19, 2023